Statistical Equivalence Analysis

Jerrycret6808 Jan, 2024Technology

What Is Equivalence Analysis? Biosimilars are safe, affordable and effective treatment alternatives as almost an identical copy of its originator. Because of unavoidable differences in the manufacturing processes, a biosimilar is not likely to be entirely identical to the reference product. An equivalence trial should show that the proposed biosimilar has neither decreased nor increased activity relative to the reference product, in other words, neither the biosimilar nor the reference product is superior or inferior to the other.